Literature DB >> 16335390

[Follow-up study for newborns and infants who failed hearing screening].

Li-Hui Huang1, De-Min Han, Sha Liu, Ling-Yan Mo, Lei Shi, Hua Zhang, Bo Liu, Bei-Er Qi, Wei Zhang, Yi-Ling Yang, Xiao-Qing Tang, Jin-Hong Xing.   

Abstract

OBJECTIVE: To study the audiological characteristics of newborns and infants who failed hearing screening.
METHODS: One hundred and six infants failed hearing screening received follow-up study with routine audiological evaluations (auditory brainstem response, distortion product otoacoustic emission, tympanometry and visual reinforcement audiometry).
RESULTS: Sixty-five infants (61.3%) of this group were normal hearing subjects and 39(36. 8% ) of the infants had hearing loss. Two cases (1.9%) received follow-up by phone. Fifteen cases (14.2%) with conductive hearing loss and 24 cases (22.6%) with sensorineural hearing loss. Thirteen (12.3%), 14 (13.2%), 6 (5.7%), and 6 (5.7%) cases were found to be mild, moderate, severe and profound hearing loss respectively. Diagnosis of hearing loss in the thirty-nine infants conducted a prevalence of 0.264% (39/14 785) of congenital hearing loss (both binaural and monaural). The hearing level of those cases with severe and profound hearing loss basically did not change, but that of cases with mild and moderate hearing loss changed.
CONCLUSIONS: Early identification and intervention of infants with severe and profound hearing loss by 6 months of age were successful. Infants with mild and moderate hearing loss should be followed up to six or eight months and received routine audiologic evaluations.

Entities:  

Mesh:

Year:  2005        PMID: 16335390

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  1 in total

1.  Assessment of the feasibility and coverage of a modified universal hearing screening protocol for use with newborn babies of migrant workers in Beijing.

Authors:  Beier Qi; Xiaohua Cheng; Hui En; Bo Liu; Shichun Peng; Yong Zhen; Zhenghua Cai; Lihui Huang; Luo Zhang; Demin Han
Journal:  BMC Pediatr       Date:  2013-08-08       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.